• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ERJ Open Res . The role of bronchoscopy in patients with SARS-CoV-2 pneumonia

tetano

Editor, Senior Moderator
ERJ Open Res


. 2021 Jul 12;7(3):00165-2021.
doi: 10.1183/23120541.00165-2021. eCollection 2021 Jul.
The role of bronchoscopy in patients with SARS-CoV-2 pneumonia


Marisol Arenas-De Larriva[SUP] 1 [/SUP], Roberto Martín-DeLeon[SUP] 2 [/SUP], Blanca Urrutia Royo[SUP] 3 [/SUP], Iker Fernández-Navamuel[SUP] 4 [/SUP], Andrés Gimenez Velando[SUP] 4 [/SUP], Laura Nuñez García[SUP] 4 [/SUP], Carmen Centeno Clemente[SUP] 5 [/SUP], Felipe Andreo García[SUP] 5 [/SUP], Albert Rafecas Codern[SUP] 6 [/SUP], Carmen Fernández-Arias[SUP] 6 [/SUP], Virginia Pajares Ruiz[SUP] 6 [/SUP], Alfons Torrego Fernández[SUP] 6 [/SUP], Olga Rajas[SUP] 7 [/SUP], Gorane Iturricastillo[SUP] 8 [/SUP], Ricardo Garcia Lujan[SUP] 9 [/SUP], Lorena Comeche Casanova[SUP] 10 [/SUP], Albert Sánchez-Font[SUP] 11 [/SUP], Ricardo Aguilar-Colindres[SUP] 12 [/SUP], Roberto Larrosa-Barrero[SUP] 13 [/SUP], Ruth García García[SUP] 14 [/SUP], Rosa Cordovilla[SUP] 14 [/SUP], Ana Núñez-Ares[SUP] 15 [/SUP], Andrés Briones-Gómez[SUP] 16 [/SUP], Enrique Cases Viedma[SUP] 16 [/SUP], José Franco[SUP] 17 [/SUP], Javier Cosano Povedano[SUP] 18 [/SUP], Manuel Luis Rodríguez-Perálvarez[SUP] 19 [/SUP], Jose Joaquin Cebrian Gallardo[SUP] 20 [/SUP], Manuel Nuñez Delgado[SUP] 21 [/SUP], María Pavón-Masa[SUP] 22 [/SUP], Maria Del Mar Valdivia Salas[SUP] 23 [/SUP], Javier Flandes[SUP] 24 [/SUP]



Affiliations

Abstract

Background: The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate.
Patients and methods: This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression.
Results: A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years; 73% men), stratified into a clinical suspicion cohort (n=30) and a COVID-19 confirmed cohort (n=485). In the clinical suspicion cohort, the diagnostic yield was 36.7%. In the COVID-19 confirmed cohort, bronchoscopies were predominantly performed in the intensive care unit (n=961; 96.4%) and major indications were: difficult mechanical ventilation (43.7%), mucus plugs (39%) and persistence of radiological infiltrates (23.4%). 147 bronchoscopies were performed to rule out superinfection, and diagnostic yield was 42.9%. There were abnormalities in 91.6% of bronchoscopies, the most frequent being mucus secretions (82.4%), haematic secretions (17.7%), mucus plugs (17.6%), and diffuse mucosal hyperaemia (11.4%). The independent predictors of in-hospital mortality were: older age (OR 1.06; p<0.001), mucus plugs as indication for bronchoscopy (OR 1.60; p=0.041), absence of mucosal hyperaemia (OR 0.49; p=0.041) and the presence of haematic secretions (OR 1.79; p=0.032).
Conclusion: Bronchoscopy may be indicated in carefully selected patients with COVID-19 to rule out superinfection and solve complications related to mechanical ventilation. The presence of haematic secretions in the distal bronchial tract may be considered a poor prognostic feature in COVID-19.
 
Back
Top Bottom